<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00512213</url>
  </required_header>
  <id_info>
    <org_study_id>P00/07 CHV</org_study_id>
    <nct_id>NCT00512213</nct_id>
  </id_info>
  <brief_title>Immunonutrition Versus Standard Enteral Nutrition Before Major Surgery</brief_title>
  <official_title>Immunonutrition Versus Standard Enteral Nutrition Before Major Surgery: A Single-center Double-blinded Controlled Randomized Superiority Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Lausanne Hospitals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this trial is to compare preoperative Imunnonutrition with standard enteral&#xD;
      nutrition regarding morbidity after major abdominal surgery in patients with NRS greater 3.&#xD;
&#xD;
      The primary end point is the complication rate until 30 days after surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Malnutrition affects about 20-50% of all patients in hospital [1, 2]. Major surgery further&#xD;
      increases postoperative malnutrition and immunity reduction. Therefore, postoperative&#xD;
      complication and infection rates after major surgery exceed 30% [3-6].&#xD;
&#xD;
      The nutritional risk score (NRS) [1] is based on the ESPEN (European society of parenteral&#xD;
      and enteral nutrition) screening guidelines and identifies patients who are likely to benefit&#xD;
      from nutritional support. Patients with a NRS ≥ 3 are considered severely undernourished, or&#xD;
      to have a certain degree of severity of disease in combination with certain degree of&#xD;
      malnutrition [7].&#xD;
&#xD;
      In a prospective cohort study patients with a NRS ³ 3 had significant more infectious and&#xD;
      overall complications after major abdominal surgery [4, 7, 8]. Several studies showed a&#xD;
      benefit by nutritional support on complications [3, 5, 6]. International guidelines suggest&#xD;
      therefore preoperative oral nutritional support for malnourished patients undergoing major&#xD;
      surgery [9]. However, it remains controversial whether standard enteral nutrition (SEN) or&#xD;
      immunonutrition (IN) is preferable [9].&#xD;
&#xD;
      IN, containing arginine, ribonucleic acid and omega-3 polyunsaturated fatty acids aims to&#xD;
      improve the nutritional status, immunological function and clinical outcome [5, 10].&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>complications after surgery</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>hospital stay, patient compliance, Interleukin-6 and 10 plasma level</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">154</enrollment>
  <condition>Major Abdominal Surgery</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Immunonutrition containing RNA, omega-3-FAs, arginine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard enteral nutrition: isocaloric and isonitrogeneous but w/o active ingredients</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Immunonutrition for 5 days preoperative</intervention_name>
    <description>Impact vs Meritene</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Impact, Meritene</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Standard enteral nutrition for 5 days preoperative</intervention_name>
    <description>Impact vs Meritene</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Impact vs Meritene</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients admitted for elective major abdominal surgery:&#xD;
&#xD;
               -  Open and laparoscopic esophageal, gastric, hepatic, pancreatic, intestinal and&#xD;
                  colorectal surgery and with a NRS ≥ 3.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 years&#xD;
&#xD;
          -  No informed consent&#xD;
&#xD;
          -  Emergency situation&#xD;
&#xD;
          -  Patients not speaking french or german.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas Demartines, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Visceral Surgery, University Hospital Center, Lausanne, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Visceral Surgery, University Hospital Center</name>
      <address>
        <city>Lausanne</city>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <study_first_submitted>August 6, 2007</study_first_submitted>
  <study_first_submitted_qc>August 6, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2007</study_first_posted>
  <last_update_submitted>April 21, 2012</last_update_submitted>
  <last_update_submitted_qc>April 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 24, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne Hospitals</investigator_affiliation>
    <investigator_full_name>Nicolas DEMARTINES</investigator_full_name>
    <investigator_title>professor of surgery</investigator_title>
  </responsible_party>
  <keyword>preoperative Immunonutrition</keyword>
  <keyword>major abdominal surgery</keyword>
  <keyword>complication</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

